Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Fatty's Donut Shop -- Ignore unavailable to you. Want to Upgrade?

To: Matt Brown who wrote (2027)	6/30/1999 9:00:00 PM
From: KZAP	Respond to of 5041

Evening Matt! QTEK looked strong right before the close. I think it was a ploy to make the little shorters cover quick. (not a short squeeze, the short was very small) I don't know if they covered yet. Not a big issue either way. But the % gain looked impressive. But take into consideration that at the close yesterday we had a seller of 3K shares. At today's close, we had strong buyers. Makes for the appearence of a large increase. Look for news tomorrow. More upward movement coming as word gets around. Happy investing! KZAP BTW, RTIN up strong today too. News on it closeing the FB deal soon?

To: Matt Brown who wrote (2027)	7/1/1999 1:23:00 PM
From: Eric Freeman	Read Replies (1) \| Respond to of 5041

PSMA - Prostate-specific Membrane Antigen Article:Cancer Research 59, 3192-3198, July 1, 1999 " Copyright 1999 by the American Association for Cancer Research Five Different Anti-Prostate-specific Membrane Antigen(PSMA) Antibodies Confirm PSMA Expression in Tumor-associated Neovasculature1 What does it all mean? I will put it this way: You want a "magic bullet" that can flag the presence of cancer, and then you want to locate the tumour, target it and deliver something to get rid of it. PSMA is quite possibly the answer. At the very least you should have highly accurate tests which identify the fact that there is cancer present. Would you like to be able to take such a definitive test? Further, in Seattle, Dr. Murphy is carrying out studies on a vaccine for prostate cancer using this technology. The potential for PSMA is in no way reflected in the valuation of CYTO and I expect the volumes to date are just the first group of in the know people taking up positions. The fact that Cytogen is such a pounded down stock means lots of resistance, retracings, etc. etc. That is the opportunity both long term and for trading it. Look at the swings in just the last two weeks. Need more information: go to the Yahoo board, as the SI board is very limited in information to date. I obviously have postions, I do say do your own homework. But anyone investigating and looking at Cytogen would conclude it is a very good risk/reward situation. Upside big, downside small. Eric